{
    "Trade/Device Name(s)": [
        "DS-A Blood Glucose Monitoring System",
        "A-CHECK DS-A Blood Glucose Monitoring System",
        "DS-A Test Strips",
        "Alliance Blood Glucose 3 levels Control Solution"
    ],
    "Submitter Information": "ALLIANCE International Co., Ltd.",
    "510(k) Number": "K082965",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043474"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW",
        "JJX"
    ],
    "Summary Letter Date": "November 20, 2009",
    "Summary Letter Received Date": "December 01, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "POCT"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "A-CHECK DS-A Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Capillary action"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Test Strips",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for DS-A Blood Glucose Monitoring System for over-the-counter and professional quantitative measurement of blood glucose in capillary whole blood.",
    "Indications for Use Summary": "Intended for at-home and professional monitoring of glucose in fresh capillary whole blood from the finger to aid diabetes management; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}